- Home
- MHH vs ACET Comparison
MHH vs ACET Comparison
Compare MHH & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHH
- ACET
- Stock Information
- Founded
- MHH 1986
- ACET 1947
- Country
- MHH United States
- ACET United States
- Employees
- MHH N/A
- ACET N/A
- Industry
- MHH Professional Services
- ACET Biotechnology: Pharmaceutical Preparations
- Sector
- MHH Consumer Discretionary
- ACET Health Care
- Exchange
- MHH Nasdaq
- ACET Nasdaq
- Market Cap
- MHH 86.6M
- ACET 69.9M
- IPO Year
- MHH N/A
- ACET N/A
- Fundamental
- Price
- MHH $7.14
- ACET $0.99
- Analyst Decision
- MHH
- ACET Buy
- Analyst Count
- MHH 0
- ACET 4
- Target Price
- MHH N/A
- ACET $6.00
- AVG Volume (30 Days)
- MHH 9.7K
- ACET 2.3M
- Earning Date
- MHH 11-05-2025
- ACET 11-05-2025
- Dividend Yield
- MHH N/A
- ACET N/A
- EPS Growth
- MHH N/A
- ACET N/A
- EPS
- MHH 0.07
- ACET N/A
- Revenue
- MHH $200,000,000.00
- ACET N/A
- Revenue This Year
- MHH N/A
- ACET N/A
- Revenue Next Year
- MHH $3.78
- ACET N/A
- P/E Ratio
- MHH $94.81
- ACET N/A
- Revenue Growth
- MHH 5.16
- ACET N/A
- 52 Week Low
- MHH $6.20
- ACET $0.45
- 52 Week High
- MHH $16.00
- ACET $1.54
- Technical
- Relative Strength Index (RSI)
- MHH 40.27
- ACET 62.45
- Support Level
- MHH $7.00
- ACET $0.90
- Resistance Level
- MHH $7.55
- ACET $1.09
- Average True Range (ATR)
- MHH 0.30
- ACET 0.09
- MACD
- MHH -0.05
- ACET 0.01
- Stochastic Oscillator
- MHH 17.78
- ACET 68.41
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.